All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Novartis AG, of Basel, Switzerland, is acquiring specialty dermatology generics company Fougera Pharmaceuticals Inc., of Melville, N.Y., from a Nordic Capital-led consortium for nearly $1 .53 billion in cash. Fougera will become part of Sandoz, Novartis' generic drug division.